Cycle length statistics during human atrial fibrillation reveal refractory properties of the underlying substrate: a combined in silico and clinical test of concept study. (4th March 2021)

• Record Type: Journal Article
• Authors: Unger, Laura A; Azzolin, Luca; Nothstein, Mark; Sánchez, Jorge; Luik, Armin; Seemann, Gunnar; Yeshwant, Srinath; Oesterlein, Tobias; Dössel, Olaf; Schmitt, Claus; Spector, Peter; Loewe, Axel
• Is Part Of: Europace. Volume 23:Supplement 1(2021)
• Page Start: i133
• Page End: i142
• Publication Date: 2021-03-04
• Subjects: Cycle length mapping -- Atrial fibrillation -- Effective refractory period -- Substrate mapping; Arrhythmia -- Treatment -- Periodicals; Cardiac pacing -- Periodicals; Catheter ablation -- Periodicals; Heart -- Physiology -- Periodicals; Electrophysiology -- Periodicals; 617.4120645
• DOI: 10.1093/europace/euaa404
• Languages: English
• ISSNs: 1099-5129

Abstract

Abstract: Aims: The treatment of atrial fibrillation beyond pulmonary vein isolation has remained an unsolved challenge. Targeting regions identified by different substrate mapping approaches for ablation resulted in ambiguous outcomes. With the effective refractory period being a fundamental prerequisite for the maintenance of fibrillatory conduction, this study aims at estimating the effective refractory period with clinically available measurements. Methods and results: A set of 240 simulations in a spherical model of the left atrium with varying model initialization, combination of cellular refractory properties, and size of a region of lowered effective refractory period was implemented to analyse the capabilities and limitations of cycle length mapping. The minimum observed cycle length and the 25% quantile were compared to the underlying effective refractory period. The density of phase singularities was used as a measure for the complexity of the excitation pattern. Finally, we employed the method in a clinical test of concept including five patients. Areas of lowered effective refractory period could be distinguished from their surroundings in simulated scenarios with successfully induced multi-wavelet re-entry. Larger areas and higher gradients in effective refractory period as well as complex activation patterns favour the method. The 25% quantile of cycle lengths in patients with persistent atrial fibrillation was found to range from 85 to 190 ms. Conclusion: Cycle length mapping is capable of highlighting regions of pathologic refractory properties. In combination with complementary substrate mapping approaches, the method fosters confidence to enhance the treatment of atrial fibrillation beyond pulmonary vein isolation particularly in patients with complex activation patterns. Graphical Abstract: